Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hayes, Daniel
One or more keywords matched the following items that are connected to Hayes, Daniel
Item TypeName
Concept Neoplasm Recurrence, Local
Concept Recurrence
Academic Article Breast cancer. Clinical practice guidelines in oncology.
Academic Article American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
Academic Article CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
Academic Article Indications for prognostic gene expression profiling in early breast cancer.
Academic Article Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.
Academic Article Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.
Academic Article Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.
Academic Article Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
Academic Article Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Academic Article Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
Academic Article Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification for early vs. late recurrences.
Academic Article Clinical practice. Follow-up of patients with early breast cancer.
Academic Article Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.
Academic Article Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Academic Article Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.
Academic Article Promoting quality and evidence-based care in early-stage breast cancer follow-up.
Academic Article Breast-Cancer Recurrence after Stopping Endocrine Therapy.
Academic Article Factors influencing the use of extended adjuvant endocrine therapy.
Academic Article Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
Academic Article Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Academic Article Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Academic Article Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
Academic Article Breast cancer, version 3.2013: featured updates to the NCCN guidelines.
Academic Article 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Academic Article 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
Academic Article Circulating Tumor Cells.
Academic Article Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harm.
Academic Article Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Academic Article Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Academic Article Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Academic Article Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
Search Criteria
  • Recurrence